Mirae Asset Global Investments’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,285
| Closed | -$86.9K | – | 1639 |
|
|
2024
Q3 | $86.9K | Buy |
3,285
+583
| +22% | +$15.4K | ﹤0.01% | 1212 |
|
|
2024
Q2 | $65.7K | Sell |
2,702
-332,015
| -99% | -$8.07M | ﹤0.01% | 1194 |
|
|
2024
Q1 | $7.62M | Buy |
334,717
+149,234
| +80% | +$3.4M | 0.02% | 749 |
|
|
2023
Q4 | $3.55M | Sell |
185,483
-228,288
| -55% | -$4.37M | 0.01% | 1021 |
|
|
2023
Q3 | $6.64M | Buy |
413,771
+32,823
| +9% | +$526K | 0.01% | 775 |
|
|
2023
Q2 | $8.83M | Buy |
380,948
+45,462
| +14% | +$1.05M | 0.02% | 705 |
|
|
2023
Q1 | $7.79M | Buy |
335,486
+10,064
| +3% | +$234K | 0.02% | 733 |
|
|
2022
Q4 | $4.72M | Sell |
325,422
-74,151
| -19% | -$1.08M | 0.01% | 844 |
|
|
2022
Q3 | $7.62M | Buy |
399,573
+52,099
| +15% | +$994K | 0.02% | 672 |
|
|
2022
Q2 | $6.31M | Buy |
347,474
+107,368
| +45% | +$1.95M | 0.02% | 761 |
|
|
2022
Q1 | $6.05M | Sell |
240,106
-44,553
| -16% | -$1.12M | 0.01% | 814 |
|
|
2021
Q4 | $7.86M | Buy |
284,659
+61,532
| +28% | +$1.7M | 0.02% | 752 |
|
|
2021
Q3 | $7.21M | Buy |
223,127
+43,986
| +25% | +$1.42M | 0.02% | 743 |
|
|
2021
Q2 | $5.48M | Buy |
179,141
+8,998
| +5% | +$275K | 0.02% | 796 |
|
|
2021
Q1 | $5.18M | Buy |
170,143
+72,491
| +74% | +$2.21M | 0.02% | 726 |
|
|
2020
Q4 | $1.93M | Buy |
97,652
+22,240
| +29% | +$440K | 0.01% | 942 |
|
|
2020
Q3 | $984K | Buy |
75,412
+23,544
| +45% | +$307K | ﹤0.01% | 974 |
|
|
2020
Q2 | $589K | Buy |
+51,868
| New | +$589K | ﹤0.01% | 1091 |
|